Analyst Ratings for Jazz Pharmaceuticals (JAZZ)
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $307.00 (UBS)
- Lowest: $226.00 (Deutsche Bank)
- Average: $261.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$261.00 (+5.4%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
Avg. $ Target:
$261.00 (+5.4%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Canaccord | Gary Newman | New Coverage | Buy (N/A) |
290.00 (N/A) |
239.32 (247.53) |
3.43% | Details |
| 6/9/2026 | Truist Securities » Updated 7/7/2026 |
Gregory Renza | New Coverage | Buy (N/A) |
254.00 (256.00) |
232.04 (247.53) |
6.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
